CN101797309A - Traditional Chinese medicine for treating scleriasis and venereal disease - Google Patents
Traditional Chinese medicine for treating scleriasis and venereal disease Download PDFInfo
- Publication number
- CN101797309A CN101797309A CN200910071387A CN200910071387A CN101797309A CN 101797309 A CN101797309 A CN 101797309A CN 200910071387 A CN200910071387 A CN 200910071387A CN 200910071387 A CN200910071387 A CN 200910071387A CN 101797309 A CN101797309 A CN 101797309A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- treating
- scleriasis
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating scleriasis and venereal disease, which is prepared from the following raw materials in parts by weight: 1-3 parts of muskiness, 9-11 parts of heracleum hemsleyanum michaux, 9-11 parts of ginseng, 9-11 parts of borneol, 11-13 parts of catechu, 1-3 parts of divaricate saposhnikovia root, 4-6 parts of garden balsam stem, 4-6 parts of saffron, 4-6 parts of frankincense, 4-6 parts of myrrh, 4-6 parts of bezoar, 0.8-1.4 parts of mercurous chloride, 0.08-0.12 part of red Canadian pine, 9-11 parts of escargots and 4-6 parts of indigo. The materials are dried and crushed for passing through a sieve with 100 meshes, are uniformly mixed and added with vaseline to obtain an external ointment. The traditional Chinese medicine has the functions of dredging meridians, relieve itching and pain, activating blood circulation to dissipate blood stasis, cooling blood and calming the heart, detoxifying, dispelling the wind, relieving itching, softening the harden skin, desquamating, promoting tissue regeneration and eliminating the caries, can achieve the aim of treating intractable cortex deterioration and can be used for treating various scleriasis and venereal diseases.
Description
Technical field: the present invention relates to Chinese medicine, particularly treat the Chinese medicine of scleroderma, sexually transmitted disease (STD).
Background technology: treat all bad side effect in addition of the general effect of Western medicine of scleroderma, sexually transmitted disease (STD) at present, and the Chinese medicine curative effect of treatment scleroderma, sexually transmitted disease (STD) is all undesirable, does not also have to eradicate or obvious results Chinese medicine, addressing this problem becomes urgent need.
The content of invention: overcome the deficiency that prior art exists, propose a kind of Chinese medicine of curing scleroderma, sexually transmitted disease (STD).This Chinese medicine is to be made by following bulk drugs: Moschus 1-3 part, Radix Angelicae Pubescentis 9-11 part, Radix Ginseng 9-11 part, Borneolum Syntheticum 9-11 part, catechu 11-13 part, Radix Saposhnikoviae 1-3 part, Herba speranskiae tuberculatae 4-6 part; Stigma Croci 4-6 part, Olibanum 4-6 part, Myrrha 4-6 part, Calculus Bovis 4-6 part, Calomelas 0.8-1.4, Hydrargyri Oxydum Rubrum 0.08-0.12, Cipangopaludina chinensis 9-11 part, Indigo Naturalis 4-6 part; to cross 100 mesh sieves with the above-mentioned medicine drying and crushing of respectively distinguishing the flavor of, mixed evenly back adds vaseline promptly becomes external-applied ointment.Chinese medicine of the present invention has the meridian dredging, antipruritic pain relieving, activating blood circulation to dissipate blood stasis, removing heat from blood mind calming, detoxification dispelling wind for relieving itching, softening sclerderm, decortication, granulation promoting putrefaction removing, can reach treatment intractable cortex and worsen.
The specific embodiment: get Moschus 3kg, Radix Angelicae Pubescentis 9kg, Radix Ginseng 9kg, Borneolum Syntheticum 9kg, catechu 11kg, Radix Saposhnikoviae 1kg, Herba speranskiae tuberculatae 4kg, Stigma Croci 4kg, Olibanum 4kg, Myrrha 4kg, Calculus Bovis 4kg, Calomelas 0.8kg, Hydrargyri Oxydum Rubrum 0.08kg, Cipangopaludina chinensis 9kg, Indigo Naturalis 4kg; to cross 100 mesh sieves with the above-mentioned medicine drying and crushing of respectively distinguishing the flavor of, mixed evenly back adds vaseline promptly becomes external-applied ointment.
Second embodiment of the present invention; get Moschus 1kg, Radix Angelicae Pubescentis 11kg, Radix Ginseng 11kg, Borneolum Syntheticum 11kg, catechu 13kg, Radix Saposhnikoviae 3kg, Herba speranskiae tuberculatae 6kg, Stigma Croci 6kg, Olibanum 6kg, Myrrha 6kg, Calculus Bovis 6kg, Calomelas 1.4kg, Hydrargyri Oxydum Rubrum 0.12kg, Cipangopaludina chinensis 11kg, Indigo Naturalis 6kg; to cross 100 mesh sieves with the above-mentioned medicine drying and crushing of respectively distinguishing the flavor of, mixed evenly back adds vaseline promptly becomes external-applied ointment.
Estimate the clinical medicine safety of Chinese medicine of the present invention, it carried out toxicity test research, be reported as follows:
1. be subjected to test product: Chinese medicine every day of treatment scleroderma, sexually transmitted disease (STD) 2 times, each 2 grams.
2. experimental animal: the white mice of Kunming kind, body weight 18-22 gram, male and female dual-purpose.
3. the preparation of dosage and test drug: the Chinese medicine of getting treatment scleroderma, sexually transmitted disease (STD).
4 grams are put and are added the 10.0ml distilled water in the mortar and be uniformly dispersed, and make solution.Administering mode is a gastric infusion.
The mensuration of median lethal dose(LD 50)
Get 9 of mices, divide three groups, but fail to find out the dosage of 100% animal dead.
Select 50 of the healthy mices of body weight 20 ± 2g for use, male and female half and half are divided into five groups at random, an oral administration gavage administration, and dosage is by geometric progression, and maximum dose level calculates with the maximum volume that can accept.Observed 7 days none death as a result after the administration.
Mtd test
Select 20 of healthy mices, male and female half and half, normally raise 1 after, administration is 2 times in 24 hours, observes continuously 7 12 hours blanking times, does not see untoward reaction and death condition, can think the oral avirulence of this medicine.
Calculate if obey 4 grams every day by the adult, the result is 240 times of normal clinical dosage, illustrates that a kind of Chinese medicine for the treatment of scleroderma, sexually transmitted disease (STD) has safety.
A kind of Chinese medicine clinical summary for the treatment of scleroderma, sexually transmitted disease (STD)
One group to the statistics in the scleroderma patients clinical observations, and this organizes 5% case for observing the patient of treatment.Man's 43 examples wherein, women 16 examples, age 2-13 year 10 examples, 51-60 year 30 examples, 24 examples more than 61 years old, wherein Therapeutic Method is the patient to be divided into two groups at random, 39 examples are organized in treatment, are coated with to spread external-applied ointment of the present invention.Once a day, the scleroderma patient 60 days was a course of treatment; Matched group 20 other medicines of example clothes, 60 days is a course of treatment, withdraws other medicines before the administration, all does inspection before and after the treatment, the result shows that the treatment group effective percentage that uses Chinese medicine of the present invention is 100%, and matched group does not have obvious effects.
One group to the statistics in the STD patients clinical observation material, and this organizes 5% case for observing the patient of treatment.Man's 23 examples wherein, women 30 examples, age 30-50 year 15 examples, 51-60 year 25 examples, 13 examples more than 61 years old, wherein Therapeutic Method is the patient to be divided into two groups at random, 33 examples are organized in treatment, are coated with to spread external-applied ointment of the present invention.Once a day, std patient 7 days was a course of treatment; Matched group 15 other medicines of example clothes are withdrawn other medicines before the administration, all do inspection before and after the treatment, and the result shows that the treatment group effective percentage that uses Chinese medicine of the present invention is 100%, and matched group does not have obvious effects.
Claims (2)
1. Chinese medicine for the treatment of scleroderma, sexually transmitted disease (STD); it is characterized in that: this Chinese medicine is to be made by following bulk drugs: Moschus 1-3 part, Radix Angelicae Pubescentis 9-11 part, Radix Ginseng 9-11 part, Borneolum Syntheticum 9-11 part, catechu 11-13 part, Radix Saposhnikoviae 1-3 part, Herba speranskiae tuberculatae 4-6 part, Stigma Croci 4-6 part, Olibanum 4-6 part, Myrrha 4-6 part, Calculus Bovis 4-6 part, Calomelas 0.8-1.4, Hydrargyri Oxydum Rubrum 0.08-0.12, Cipangopaludina chinensis 9-11 part, Indigo Naturalis 4-6 part.
2. according to the described Chinese medicine of claim 1, it is characterized in that: its production technology is to cross 100 mesh sieves with the above-mentioned medicine drying and crushing of respectively distinguishing the flavor of, and mixed evenly back adds vaseline promptly becomes external-applied ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910071387A CN101797309A (en) | 2009-02-06 | 2009-02-06 | Traditional Chinese medicine for treating scleriasis and venereal disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910071387A CN101797309A (en) | 2009-02-06 | 2009-02-06 | Traditional Chinese medicine for treating scleriasis and venereal disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101797309A true CN101797309A (en) | 2010-08-11 |
Family
ID=42593250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910071387A Pending CN101797309A (en) | 2009-02-06 | 2009-02-06 | Traditional Chinese medicine for treating scleriasis and venereal disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101797309A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102362918A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | Chinese patent medicament for treating scleroderma |
| CN105597066A (en) * | 2016-02-03 | 2016-05-25 | 房现刚 | Traditional Chinese medicine composition for treating diffuse systemic scleroderma |
| CN105998157A (en) * | 2016-07-11 | 2016-10-12 | 洪志 | Traditional Chinese medicine powder for treating sexually-transmitted diseases |
-
2009
- 2009-02-06 CN CN200910071387A patent/CN101797309A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102362918A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | Chinese patent medicament for treating scleroderma |
| CN105597066A (en) * | 2016-02-03 | 2016-05-25 | 房现刚 | Traditional Chinese medicine composition for treating diffuse systemic scleroderma |
| CN105998157A (en) * | 2016-07-11 | 2016-10-12 | 洪志 | Traditional Chinese medicine powder for treating sexually-transmitted diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766773B (en) | Chinese medicine prescription for treating talagia | |
| CN102166277A (en) | Waist healing pill | |
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN1836715A (en) | External use medicine for quickly treating herpes zoster | |
| CN1927286A (en) | Chinese medicine composition for treating skin disease | |
| CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
| CN101797309A (en) | Traditional Chinese medicine for treating scleriasis and venereal disease | |
| CN101450094B (en) | Medicine for treating herpes zoster | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN107412640B (en) | External ointment for assisting acupuncture and moxibustion physiotherapy | |
| CN105168286A (en) | Externally-applied medicine for treating herpes zoster | |
| CN114177160A (en) | Foot patch for treating dental ulcer and preparation method thereof | |
| CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN113082103A (en) | Traditional Chinese medicine composition for treating traumatic injury and sprain and preparation method thereof | |
| CN103263598B (en) | Chinese medicine preparation for treating peripheral facial paralysis diseases | |
| CN102319330B (en) | Traditional Chinese medicine cataplasma for treating hyperosteogeny and preparation method thereof | |
| CN102784355B (en) | First-aid drug and preparation method thereof | |
| CN102670740B (en) | Drug composition for treating soft tissue injuries and preparation process thereof | |
| CN101810668A (en) | Toxin drawing plaster | |
| CN101342226A (en) | Chinese traditional medicine for treating psoriasis | |
| CN1233333C (en) | Process for preparing Tibetan medicines | |
| CN100360154C (en) | Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease | |
| CN101297937B (en) | Chinese patent medicine formulation for treating cervical vertebra disease and preparation thereof | |
| CN106377713A (en) | Traditional Chinese medicinal compound preparation for treating herpes zoster | |
| CN102114238A (en) | Ointment for treating herpes zoster and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100811 |